At x0.6 for shareholders’ equity, despite a plethora of excess cash and a good track record of profitability, less than x4 for net income expected this year, and a dividend yield of almost 9%, it’s hard not to salivate at the stock’s valuation ratios.
Notwithstanding all the healthy reservations th…
© MarketScreener.com 2024
Notwithstanding all the healthy reservations th…
© MarketScreener.com 2024